Clinical Trial: Clinical Study of Ivonescimab Combined With Concurrent Chemoradiotherapy in the Treatment of Advanced Non-small Cell Lung Cancer

U.S., Nov. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07936578) titled 'Clinical Study of Ivonescimab Combined With Concurrent Chemoradiotherapy in the Treatment of Advanced Non-small Cell Lung Cancer' on Oct. 26.

Brief Summary: This prospective, exploratory study will evaluate the objective response rate (ORR), progression-free survival (PFS), overall survival (OS), and toxicity of ivonescimab plus chemotherapy for 2-4 cycles after concurrent chemoradiotherapy, followed by 2 years of ivonescimab maintenance therapy, in patients with stage IV non-small cell lung cancer (NSCLC). The findings will be compared with those of previous studies and with our institutional data on patients with stage IV NSCLC wh...